Score Overview
Explore the 2021 public Archive ranking →
Where Achieve Life Sciences Inc has ranked, year by year
Showing all available years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- ACHV
2001: 95.4% · 2021: 97.3% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-30 | $ 8.09 | — |
1 Year2025-09-30 | $ 3.15 | 156.83% |
5 Years2021-09-30 | $ 8.50 | -4.82% |
10 Years2016-09-30 | $ 1.12K | -99.27% |
20 Years2006-09-29 | $ 185.72K | -100.00% |
30 Years1996-09-27 | $ 772.2K | -100.00% |
All Time1995-10-13 | $ 282.15K | -100.00% |
| Period | Last Price2026-09-30 | 1 Year2025-09-30 | 5 Years2021-09-30 | 10 Years2016-09-30 | 20 Years2006-09-29 | 30 Years1996-09-27 | All Time1995-10-13 |
|---|---|---|---|---|---|---|---|
| Price | $ 8.09 | $ 3.15 | $ 8.50 | $ 1.12K | $ 185.72K | $ 772.2K | $ 282.15K |
| Return | — | 156.83% | -4.82% | -99.27% | -100.00% | -100.00% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 0.00 | -$ 114M | $ 187M |
| 2025 | $ 0.00 | -$ 54M | $ 36M |
| 2024 | $ 0.00 | -$ 39M | $ 34M |
| 2023 | $ 0.00 | -$ 29M | $ 15M |
| 2022 | $ 0.00 | -$ 41M | $ 24M |
| 2021 | $ 0.00 | -$ 32M | $ 43M |
| 2020 | $ 0.00 | -$ 14M | $ 35M |
| 2019 | $ 0.00 | -$ 16M | $ 16M |
| 2018 | $ 0.00 | -$ 12M | $ 14M |
| 2017 | $ 0.00 | -$ 10M | $ 5M |
| 2016 | $ 5M | -$ 20M | $ 25M |
| 2015 | $ 18M | -$ 16M | $ 55M |
| 2014 | $ 27M | -$ 26M | $ 47M |
| 2013 | $ 29M | -$ 31M | $ 39M |
| 2012 | $ 20M | -$ 21M | $ 75M |
| 2011 | $ 5M | -$ 14M | $ 64M |
| 2010 | $ 13M | -$ 12M | $ 85M |
| 2009 | $ 25M | $ 5M | $ 64M |
| 2008 | $ 20M | -$ 4M | $ 13M |
| 2007 | $ 20M | -$ 13M | $ 34M |
| 2006 | $ 22M | -$ 23M | $ 58M |
| 2005 | $ 8M | -$ 21M | $ 49M |
| 2004 | $ 264M | -$ 16M | $ 20M |
| 2003 | -$ 10M | $ 19M | |
| 2002 | -$ 11M | $ 16M | |
| 2001 | $ 8M | $ 542.18K | $ 15M |
| 2000 | $ 408.41K | -$ 2M | $ 13M |
| 1999 | $ 12M | $ 400K | $ 16M |
| 1998 | $ 5M | -$ 11M | $ 17M |
| 1997 | $ 18M | $ 1M | $ 5M |
| 1996 | $ 16M | $ 1M | $ 7M |
| IPO1995 | $ 4M | -$ 5M | $ 5M |
Achieve Life Sciences Inc fundamental performance
Between 2005 and 2025, revenue declined from $ 8M to $ 0.00 and net income went from -$ 21M to -$ 54M. Revenue increased in 4 of those 20 years; net income in 8.
Across Achieve Life Sciences Inc's full reported history, from 1995 to 2025, revenue declined from $ 4M to $ 0.00 and net income went from -$ 5M to -$ 54M. Revenue increased in 32% of the years measured; net income in 39%.
Achieve Life Sciences Inc currently holds a 20-year HDB Score of 1.5 out of 10. How the HDB Score is calculated.
Membership
Continue ACHV’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
